Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Addressing disparities in clinical trials: Culturally and linguistically appropriate standards in clinical trials (CLAS-ACT) and the EDICT backpack initiative

Addressing disparities in clinical trials: Culturally and linguistically appropriate standards in... Journal of Cancer Education, 24:S54–S55, 2009 Copyright © AACE and EACE ISSN: 0885-8195 print / 1543-0154 online DOI: 10.1080/08858190903404536 HJCE Addressing Disparities in Clinical Trials: Culturally and Linguistically Appropriate Standards in Clinical Trials (CLAS-ACT) and the EDICT BackPack Initiative 11th ICC Biennial Symposium GARTH GRAHAM, MD, MPH; SUZANNE HEURTIN-ROBERTS, PHD, MSW tions. Yet, despite significant actions by public and private PARTICIPATION IN CLINICAL TRIALS concerns, disparities in America continue to persist. One IS A BENEFIT disparity that continues to be particularly concerning is the number of racial/ethnic minorities, the poor, and other vul- Limited participation of racial/ethnic minorities and nerable populations, who have access to and participate in other vulnerable populations in clinical trials is greatly clinical trials as opposed to the proportion of the general troubling, because participation in clinical trials may result population participating. in benefits for participant populations. Research with a In 1995, Swanson and Ward described the general diverse study sample generates treatments demonstrated as practice of recruiting participants into clinical trials as safe and effective for a broad range of populations. Partici- “embryonic at best” while finding the recruitment of a pation also gives access to potentially state-of-the-art diverse patient population even more problematic. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Cancer Education Springer Journals

Addressing disparities in clinical trials: Culturally and linguistically appropriate standards in clinical trials (CLAS-ACT) and the EDICT backpack initiative

Loading next page...
 
/lp/springer-journals/addressing-disparities-in-clinical-trials-culturally-and-hDPu7jKhCt

References (3)

Publisher
Springer Journals
Copyright
Copyright © 2009 by American Association for Cancer Education
Subject
Biomedicine; Cancer Research; Pharmacology/Toxicology
ISSN
0885-8195
eISSN
1543-0154
DOI
10.1007/BF03182314
Publisher site
See Article on Publisher Site

Abstract

Journal of Cancer Education, 24:S54–S55, 2009 Copyright © AACE and EACE ISSN: 0885-8195 print / 1543-0154 online DOI: 10.1080/08858190903404536 HJCE Addressing Disparities in Clinical Trials: Culturally and Linguistically Appropriate Standards in Clinical Trials (CLAS-ACT) and the EDICT BackPack Initiative 11th ICC Biennial Symposium GARTH GRAHAM, MD, MPH; SUZANNE HEURTIN-ROBERTS, PHD, MSW tions. Yet, despite significant actions by public and private PARTICIPATION IN CLINICAL TRIALS concerns, disparities in America continue to persist. One IS A BENEFIT disparity that continues to be particularly concerning is the number of racial/ethnic minorities, the poor, and other vul- Limited participation of racial/ethnic minorities and nerable populations, who have access to and participate in other vulnerable populations in clinical trials is greatly clinical trials as opposed to the proportion of the general troubling, because participation in clinical trials may result population participating. in benefits for participant populations. Research with a In 1995, Swanson and Ward described the general diverse study sample generates treatments demonstrated as practice of recruiting participants into clinical trials as safe and effective for a broad range of populations. Partici- “embryonic at best” while finding the recruitment of a pation also gives access to potentially state-of-the-art diverse patient population even more problematic.

Journal

Journal of Cancer EducationSpringer Journals

Published: Feb 25, 2010

There are no references for this article.